Randomized Phase II Trial of Atovaquone with Pyrimethamine or Sulfadiazine for Treatment of Toxoplasmic Encephalitis in Patients with Acquired Immunodeficiency Syndrome: ACTG 237/ANRS 039 Study-Reference-Cited by-同舟云学术

Randomized Phase II Trial of Atovaquone with Pyrimethamine or Sulfadiazine for Treatment of Toxoplasmic Encephalitis in Patients with Acquired Immunodeficiency Syndrome: ACTG 237/ANRS 039 Study

Published:2002-05 Issue:9 Volume:34 Page:1243-1250
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:CLIN INFECT DIS

Author:

Chirgwin Keith,Hafner Richard,Leport Catherine,Remington Jack,Andersen Janet,Bosler Elizabeth M.,Roque Clemente,Rajicic Natasa,McAuliffe Vincent,Morlat Philippe,Jayaweera D. T.,Vilde Jean‐Louis,Luft Benjamin J.,

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/34/9/1243/5867373/34-9-1243.pdf

Reference23 articles.

1. Toxoplasmic Encephalitis in AIDS

2. Treatment of Toxoplasmic Encephalitis in Patients with AIDS

3. Pyrimethamine-Clindamycin vs. Pyrimethamine-Sulfadiazine as Acute and Long-Term Therapy for Toxoplasmic Encephalitis in Patients with AIDS

4. Toxoplasmic Encephalitis in Patients with the Acquired Immunodeficiency Syndrome

5. Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protozoan Diseases: Toxoplasmosis;International Encyclopedia of Public Health;2025

2. Pneumocystis jirovecii pneumonia in people living with HIV: a review;Clinical Microbiology Reviews;2024-03-14

3. Overview of management of infection-related movement disorders with focus on specific-infections;Clinical Parkinsonism & Related Disorders;2024

4. Protective efficacy of Toxoplasma gondii infected cells-derived exosomes against chronic murine toxoplasmosis;Acta Tropica;2023-12

5. Anti-parasitic activity of a chimeric peptide Cecropin A (2−8)-Melittin (6−9) (CM11) against tachyzoites of Toxoplasma gondii and the BALB/c mouse model of acute toxoplasmosis;Molecular and Biochemical Parasitology;2023-09